Cargando…
The Availability and Safety Study of Remimazolam Besylate for Injection on Sedation of ERAS Patients Under Mechanical Ventilation in ICU: Protocol for a Randomized, Open-Label, Controlled Trial
Introduction: The most common physiological and psychological disorders associated with critical care patients are pain and anxiety. Sedatives and analgesics are commonly used to relieve these symptoms. However, the adverse effects of sedatives and analgesics are common and inevitable. As a new type...
Autores principales: | Liu, Shengjun, Su, Longxiang, Zhang, Bo, He, Huaiwu, Li, Zunzhu, Li, Qi, Wang, Qianlin, Smith, Fang, Long, Yun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8603912/ https://www.ncbi.nlm.nih.gov/pubmed/34805204 http://dx.doi.org/10.3389/fmed.2021.735473 |
Ejemplares similares
-
Remimazolam besylate for the sedation of postoperative patients undergoing invasive mechanical ventilation in the ICU: a prospective dose‒response study
por: Chen, Xiaoyan, et al.
Publicado: (2022) -
The effective doses of remimazolam besylate in the procedural sedation of endoscopic retrograde cholangiopancreatography
por: Tan, Dan‐Dan, et al.
Publicado: (2022) -
Remimazolam besylate versus propofol for long-term sedation during invasive mechanical ventilation: a pilot study
por: Tang, Yun, et al.
Publicado: (2022) -
Remimazolam besylate for sedation of postoperative patients in intensive care units: a phase I, open label, dose-finding study
por: Tang, Yun, et al.
Publicado: (2022) -
Remimazolam besylate versus propofol for deep sedation in critically ill patients: a randomized pilot study
por: Tang, Yun, et al.
Publicado: (2023)